SEngine Precision Medicine’s PARIS® Test to Guide Personalized Treatment Demonstrates Clinical Utility in Metastatic Colorectal Cancer Study Published in AACR’s Clinical Cancer Research

NEXT STORY
Jetson Assembles “Gut Council” of Medical Experts to Accelerate the Company Mission of Elevating Human Health Through the Power of the Gut
PREV STORY
COVID-19 Drug Associated APIs Global Market Report 2020: COVID 19 Growth and Change
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones

BEVERLY, Mass., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals to Present at Upcoming Investor Conferences

NEW YORK, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

author_avatar
NASDAQ Market News

CORRECTION: FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy Company release March 29, 2018 at 8:30 pm EET Correction to ...

author_avatar
NASDAQ Market News